These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 21285183)

  • 1. Rapidly fatal pulmonary fibrosis in a patient with psoriatic arthritis treated with adalimumab.
    Cohen JV; Capell BC; Kinniry PA; Epstein AL
    J Rheumatol; 2011 Feb; 38(2):398-9. PubMed ID: 21285183
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypertriglyceridaemia during treatment with adalimumab in psoriatic arthritis.
    Stinco G; Piccirillo F; Patrone P
    Br J Dermatol; 2007 Dec; 157(6):1273-4. PubMed ID: 17916219
    [No Abstract]   [Full Text] [Related]  

  • 3. Adalimumab-associated pulmonary fibrosis reply.
    Huggett MT; Armstrong R
    Rheumatology (Oxford); 2007 Aug; 46(8):1379-80; author reply 1379. PubMed ID: 17553912
    [No Abstract]   [Full Text] [Related]  

  • 4. Occurrence of penile intraepithelial neoplasia following adalimumab treatment for psoriatic arthritis.
    Kreuter A; Meyer MF; Wieland U
    Arch Dermatol; 2011 Aug; 147(8):1001-2. PubMed ID: 21844477
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute generalized skin eruption due to adalimumab: report of two cases.
    Dalmau J; Roé E; Corella F; García-Navarro X; Peramiquel L; Alomar A
    J Eur Acad Dermatol Venereol; 2007 Sep; 21(8):1105-6. PubMed ID: 17714134
    [No Abstract]   [Full Text] [Related]  

  • 6. Pulmonary fibrosis in a patient with rheumatoid arthritis treated with adalimumab.
    Schoe A; van der Laan-Baalbergen NE; Huizinga TW; Breedveld FC; van Laar JM
    Arthritis Rheum; 2006 Feb; 55(1):157-9. PubMed ID: 16463430
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of adalimumab on symptoms of psoriatic arthritis in patients with moderate to severe psoriasis: a pooled analysis of randomized clinical trials.
    Mease PJ; Signorovitch J; Yu AP; Wu EQ; Gupta SR; Bao Y; Mulani PM
    Dermatology; 2010; 220(1):1-7. PubMed ID: 19940437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperpigmentation of the face following adalimumab treatment.
    Blomberg M; Zachariae CO; Grønhøj F
    Acta Derm Venereol; 2009; 89(5):546-7. PubMed ID: 19734995
    [No Abstract]   [Full Text] [Related]  

  • 9. Lichenoid reaction induced by adalimumab.
    De Simone C; Caldarola G; D'Agostino M; Rotoli M; Capizzi R; Amerio P
    J Eur Acad Dermatol Venereol; 2008 May; 22(5):626-7. PubMed ID: 18005023
    [No Abstract]   [Full Text] [Related]  

  • 10. Onset of palmoplantar pustular psoriasis while on adalimumab for psoriatic arthritis: a 'class effect' of TNF-alpha antagonists or simply an anti-psoriatic treatment adverse reaction?
    Rallis E; Korfitis C; Stavropoulou E; Papaconstantis M
    J Dermatolog Treat; 2010 Jan; 21(1):3-5. PubMed ID: 19701844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatal acquired hemophilia A in a patient with rheumatoid arthritis treated with adalimumab.
    Arthanari S; Ahmad H; Nisar M
    J Clin Rheumatol; 2012 Jan; 18(1):50-1. PubMed ID: 22157274
    [No Abstract]   [Full Text] [Related]  

  • 12. Interstitial granulomatous drug reaction to adalimumab.
    Martorell-Calatayud A; Balmer N; Cardenas Cardona LF; Teague D
    Am J Dermatopathol; 2010 Jun; 32(4):408-9. PubMed ID: 19940750
    [No Abstract]   [Full Text] [Related]  

  • 13. Alopecia areata universalis elicited during treatment with adalimumab.
    Pelivani N; Hassan AS; Braathen LR; Hunger RE; Yawalkar N
    Dermatology; 2008; 216(4):320-3. PubMed ID: 18230980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morbidity and mortality in rheumatoid patients during treatment with adalimumab and infliximab.
    Molloy E; Ramakrishnan S; Murphy E; Barry M
    Rheumatology (Oxford); 2004 Apr; 43(4):522-3. PubMed ID: 15024136
    [No Abstract]   [Full Text] [Related]  

  • 15. Relationship between the clinical response to adalimumab treatment and serum levels of adalimumab and anti-adalimumab antibodies in patients with psoriatic arthritis.
    van Kuijk AW; de Groot M; Stapel SO; Dijkmans BA; Wolbink GJ; Tak PP
    Ann Rheum Dis; 2010 Mar; 69(3):624-5. PubMed ID: 20223840
    [No Abstract]   [Full Text] [Related]  

  • 16. Fatal exacerbation of fibrosing alveolitis associated with systemic sclerosis in a patient treated with adalimumab.
    Allanore Y; Devos-François G; Caramella C; Boumier P; Jounieaux V; Kahan A
    Ann Rheum Dis; 2006 Jun; 65(6):834-5. PubMed ID: 16699057
    [No Abstract]   [Full Text] [Related]  

  • 17. Pulmonary sarcoidosis in a patient with psoriatic arthritis during infliximab therapy.
    Izzi S; Francesconi F; Visca P; Altieri A; De Mutiis C; Trevisan G; Bonifati C
    Dermatol Online J; 2010 May; 16(5):16. PubMed ID: 20492833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatal fibrosing alveolitis with certolizumab.
    Millar A; McKew J; Taggart A
    Rheumatology (Oxford); 2012 May; 51(5):953-5. PubMed ID: 22328567
    [No Abstract]   [Full Text] [Related]  

  • 19. Do Anti-TNF Blockers Increase the Risk of Lung Involvement in Patients with Ankylosing Spondylitis or Psoriatic Arthritis? A Systematic Review.
    Atzeni F; Grillo E; Masala IF; Sarzi-Puttini P; Jones GT
    Isr Med Assoc J; 2016; 18(3-4):154-5. PubMed ID: 27228632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sarcoidosis appearing during anti-tumor necrosis factor alpha therapy: a new "class effect" paradoxical phenomenon. Two case reports and literature review.
    Massara A; Cavazzini L; La Corte R; Trotta F
    Semin Arthritis Rheum; 2010 Feb; 39(4):313-9. PubMed ID: 19147181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.